American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.

@article{Schrag2004AmericanSO,
  title={American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.},
  author={Deborah Schrag and Harinder S. Garewal and Harold J. Burstein and David J. Samson and Daniel Von Hoff and Mark R. Somerfield},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 17},
  pages={3631-8}
}
PURPOSE To develop a technology assessment of chemotherapy sensitivity and resistance assays in order to define the role of these tests in routine oncology practice. METHODS The American Society of Clinical Oncology (ASCO) established a Working Group to develop the technology assessment. The Working Group collaborated with the Blue Cross and Blue Shield Association (BCBSA) Technology Evaluation Center. The Working Group developed independent criteria for selecting articles for inclusion in… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 65 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Similar Papers

Loading similar papers…